Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2007
11/14/2007CN101072776A Novel diazabicyclononene derivative
11/14/2007CN101072770A Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites
11/14/2007CN101070322A 7-(4-nitroyl-3-amino-1-piperidyl) quinolinecarboxylic acid derivative, its preparing method and use
11/14/2007CN101070321A Tetrahydropyridone-1,3-diazacyclo compound and preparing method
11/14/2007CN101070320A Cyclo-heterocyclic ketene aminals containing nitro-group and its preparing method
11/14/2007CN101070304A Quinoline derivatives and their use as mycrobacterial inhibitors
11/14/2007CN100348587C Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
11/13/2007US7294738 Phosphorous containing steroid mimics
11/13/2007US7294715 E.g., 2,9-Diisopropyloxy-1,10-dimethoxy-7-oxoaporphine and 1-methoxy-2-hydroxy-9,10-methylenedioxyaporphine; are used to treat ischemic and metabolic diseases
11/13/2007US7294642 1,3-Diamino-2-hydroxypropane pro-drug derivatives
11/13/2007US7294624 Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases
11/13/2007US7294287 As optical brighteners and light stabilizers in natural and synthetic materials and as fluorescent markers in applications such as defect detection, bio- and chemical assays and security printing
11/13/2007CA2213080C 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
11/08/2007WO2007127731A1 4-squarylpiperazine derivatives as antiviral agents
11/08/2007WO2007127635A2 Diketo-piperazine and piperidine derivatives as antiviral agents
11/08/2007WO2007127138A1 Triazoloquinazolinone derivatives as inhibitors of checkpoint kinases
11/08/2007WO2007126128A1 Dihydropyrazolopyrimidinone derivative
11/08/2007WO2007126041A1 Benzisoxazole compound
11/08/2007WO2007125988A1 Novel compound having affinity to amyloid
11/08/2007WO2007125330A1 Imidazo[4, 5-b]pyridin-2-one and oxazolo[4, 5-b]pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds
11/08/2007WO2007125325A1 Pharmaceutical compounds
11/08/2007WO2007125321A2 Purine and deazapurine derivatives as pharmaceutical compounds
11/08/2007WO2007125320A1 Pharmaceutical compounds
11/08/2007WO2007125315A2 Pharmaceutical compounds
11/08/2007WO2007124903A1 Spirocyclic cyclohexane derivative with analgesic properties
11/08/2007WO2007124854A1 Heterocyclic substituted, anellated pyrazole derivative and its uses
11/08/2007WO2007107352A8 Agents that disrupt cellular replication and their use in inhibiting pathological conditions
11/08/2007WO2007067504A3 Lactam compounds and methods of using the same
11/08/2007WO2006106423A8 Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase
11/08/2007US20070259944 Amides such as 5-(3-Nitrophenyl)-1,3-dihydro-indol-2-one, used as antiprogesterones, contraceptives, for hormone replacement therapy during menopause and as anticarcinogenic agents
11/08/2007US20070259925 Dpp iv inhibitors
11/08/2007US20070259911 N-(6-tert.-Butyloxycarbonyl-3-cyano-4,5,6,7-tetrahydro-thieno[2,3-c]pyridin-2-yl)-benzamide; antiproliferative agent; anticarcinogenic agent
11/08/2007US20070259910 3-{4-[3-(2-Fluoro-5-trifluoromethylphenyl)ureido]phenyl}-1H-indole-2-carboxamide;KDR (Kinase insert Domain Receptor), Tie-2 and FAK tyrosine kinase receptor inhibitors; anticarcinogenic agents; psoriasis; antiinflammatory agents; antiarthritic agents; antidiabetic agents; Kaposi's sarcoma; hemangiomas
11/08/2007US20070259908 Mitochondria Activators
11/08/2007US20070259905 silyl camptothecin derivatives for cancer and/or leukemia; cytotoxic; DNA-topoisomerase I inhibitors; antitumor agents; 7-trimethylsilyl-10-acetoxy camptothecin, 7-trimethylsilyl-11-fluoro camptothecin
11/08/2007US20070259898 NOVEL 2-AMINO-3,4-DIHYDRO-PYRIDO[3,4-D]PYRIMIDINE DERIVATIVES USEFUL AS INHIBITORS OF beta-SECRETASE (BACE)
11/08/2007US20070259882 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
11/08/2007US20070259881 Substituted Imidazo Ring Systems and Methods
11/08/2007US20070259871 Hydroxybenzamide Derivatives And Their Use As Inhibitors Of HSP90
11/08/2007US20070259851 4-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carboxylic acid (9-benzyl-8-oxo-3,6,7,8,9,10-hexahydro-2,3,9-triaza-(R)-cyclohepta[e]inden-7-yl)-amide; calcitonin gene-related peptide receptor antagonist; analgesic, antiinflammatory agent; migraine, neurogenic vasodilation, menopause, asthma
11/08/2007US20070259045 Alcohol Resistant Dosage Forms
11/08/2007CA2657312A1 Novel compound having affinity to amyloid
11/08/2007CA2650393A1 Heterocyclyl-substituted fused pyrazole derivatives and their use
11/08/2007CA2650382A1 Diketo-piperazine and piperidine derivatives as antiviral agents
11/08/2007CA2650119A1 Dihydropyrazolopyrimidinone derivatives
11/08/2007CA2649994A1 Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds
11/08/2007CA2649811A1 Triazoloquinazolinone derivatives as inhibitors of checkpoint kinases
11/08/2007CA2649349A1 Spirocyclic cyclohexane derivatives having an analgesic action
11/07/2007EP1852434A1 Bicyclic carbamoylpyridone derivative having hiv integrase inhibiting activity
11/07/2007EP1851227A1 An efficient and stereoselective process for large scale synthesis of 3-(r)-3- (2,3-dihydrobenzofuran-5-yl)-1,2,3,4- tetrahydropyrrolo{3,4-b}quinolin-9-one
11/07/2007EP1851224A2 Hydroxyalkyl substituted imidazoquinolines
11/07/2007EP1851223A1 Process of purifying tadalafil
11/07/2007EP1851222A1 Process of synthesizing tadalafil
11/07/2007EP1851221A1 Tadalafil having a large particle size and a process for preparation thereof
11/07/2007EP1851220A2 Hydroxyalkyl substituted imidazonaphthyridines
11/07/2007EP1851219A1 Fused heterocyclic compounds useful as inhibitors of histone deacetylase
11/07/2007EP1851218A2 Hydroxyalkyl substituted imidazoquinoline compounds and methods
11/07/2007EP1851217A1 Substituted pyrido(2,3-d)pyrimidine derivatives useful as medicines for the treatment of autoimmune disorders
11/07/2007EP1851216A2 Substituted benzoquinolizines as dpp-iv inhibitors for the treatment of diabetes
11/07/2007EP1851199A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
11/07/2007EP1850849A2 Method of preferentially inducing the biosynthesis of interferon
11/07/2007EP1850843A2 Inhibitors of akt activity
11/07/2007EP1361225B1 Compounds substituted with bicyclic amino groups
11/07/2007EP1290448B1 Rare earth metal cryptates showing reduced fluorescence quenching
11/07/2007EP1192151B1 Anilinoquinazolines as protein tyrosine kinase inhibitors
11/07/2007CN101068813A Determination of nucleic acid using electrocatalytic intercalators
11/07/2007CN101068812A Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
11/07/2007CN101068811A Akt活性抑制剂 Akt activity inhibitor
11/07/2007CN101068776A Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
11/07/2007CN100347174C Heterocyclic hepyramine derivative, its preparation and use thereof
11/07/2007CN100347173C Pyrazoloquinolines with immunomodulating activity
11/07/2007CN100347172C Azaindole-derivatives as factor Xa inhibitors
11/07/2007CN100347171C Pyridine compounds and their prepn and application as Dopamine D4 receptor agonist
11/07/2007CN100346786C Substituted benzimidazole compounds and their use for the treatment of cancer
11/06/2007US7291736 3-[2-(dimethylamino)ethyl]-1-[(3-fluorophenyl)sulfonyl]-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one; anxiety disorder or a cognitive disorder; central nervous system disorders; psychological disorders; neurodegenerative disorder; attention deficit disorder; obsessive compulsive disorder; Alzheimer's
11/06/2007US7291735 Process for the manufacture of (+)-(s)-clopidogrel bisulfate form-1
11/06/2007US7291734 N-(4,5,6,7-Tetrahydro-thiazolo[5,4-c]pyridin-2-yl)sulfonamides, e.g., 2-[2-(3,5-Bis-trifluoromethyl-benzenesulfonylamino)-6,7-dihydro-4H-thiazolo[5,4-c]pyridin-5-yl]-4-trifluoromethyl-benzamide; steroid sulfatase inhibitors used to treat diseases including acne
11/06/2007US7291732 Isomeric fused pyrrolocarbazoles and isoindolones
11/06/2007US7291731 7-(3-Pyridyl)-1,7-diazaspiro-[4,4]nonane and its salts and proline amides; capable of affecting nicotinic cholinergic receptors, e.g., as modulators of specific nicotinic receptor subtypes; neuroprotective agents
11/06/2007US7291631 aminoalkylpyridines, e.g., N-(1H-benzimidazol-2-ylmethyl)-N-(3-methylpyridin-2-ylmethyl)-butane-1,4-diamine; treating HIV infection and inflammatory conditions such as rheumatoid arthritis; elevating progenitor and stem cell counts, as well as white blood cell counts
11/06/2007US7291630 Azaindoles as inhibitors of c-Jun N-terminal kinases
11/06/2007US7291629 Neurotrophin antagonist compositions
11/06/2007US7291627 E.g., 8-chloro-3,11-dimethyl-5,6-dihydroimidazo[5,1-a]- beta -carboline methane sulfonate; used for reducing alertness and/or for accelerating the onset of sleep
11/06/2007US7291622 Administering a 4-Amino-2-[1-(o-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinylcarbamate derivative, optionally mixed with an organic nitrate or NO donor or a cGMP inhibitor for treating sexual dysfunction
11/06/2007US7291612 Immunomodulatory compounds
11/06/2007US7291429 Naphthalenetetracarboxylic acid diimide derivatives and electrophotographic photoconductive material using the derivatives
11/06/2007US7291404 Organic light emitting devices
11/06/2007CA2241666C Tricyclic compounds, their production and use
11/01/2007WO2007124345A2 Beta-amyloid pet imaging agents
11/01/2007WO2007124337A1 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1
11/01/2007WO2007124288A1 Indazole compounds and methods for inhibition of cdc7
11/01/2007WO2007123953A2 Phosphodiesterase 4 inhibitors
11/01/2007WO2007123732A2 Antifungal and antiparasitic indoloquinoline derivatives
11/01/2007WO2007123269A1 Azolecarboxamide derivative
11/01/2007WO2007122466A1 Pyridine[3,4-b]pyrazinones
11/01/2007WO2007122341A2 Specific monocationic monochromophoric hydrazone compounds containing a 2-(benz)imidazolium unit, their synthesis, dyeing compositions comprising them, method of dyeing keratin fibres
11/01/2007WO2007122258A1 Tryclic nitrogen containing compounds and their use as antibacterials
11/01/2007WO2007122103A1 Diazepan derivatives modulators of chemokine receptors
11/01/2007WO2007108936A3 N-substituted-azacyclylamines as histamine-3 antagonists
11/01/2007WO2007079239A3 Bicyclic nitrogen compounds as modulators of ghrelin receptor and uses thereof
1 ... 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 ... 646